What is the Impact Factor of Reumatismo?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Reumatismo is 1.20, ranking in quartile Q4 of Web of Science (ESCI).

Is Reumatismo indexed in Web of Science or Scopus?

Yes, Reumatismo is indexed in Web of Science (ESCI, Q4 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.283 (Q4) and an H-index of 34.

Who publishes Reumatismo and what is the Article Processing Charge (APC)?

Reumatismo is published by PAGEPress Publications. It operates under a Diamond Open Access model, exempting authors completely from Article Processing Charges ($0 USD APC).

WoS ESCI Q4Scopus Q4SCImago #17,845Diamond OAHybrid

Reumatismo

Identifier (ISSN):0048-7449(Print)/2240-2683(Online)

•

Publisher:PAGEPress Publications

Clarivate JCR Index Advisory: Active (ESCI)

Official Website Submission Portal Compare

Clarivate IF (2026)

1.2↑ +0.2

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS ESCIJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2023–2026)

Clarivate IF trend for Reumatismo

WoS Q4

Annual Impact Factor Metric

Current (2026):1.2

Scopus SJR & RankScopus Q4

0.283

#17,845

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

34 papers with at least that number of citations each

WoS: ESCIQ4

Self-Citation Rate8.3%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

28articles/year

86.11% Gold OA•86.36% Original Research

Aims & Scope

Reumatismo is the official Journal of the Italian Society of Rheumatology (SIR). It publishes Abstracts and Proceedings of Italian Congresses and original papers concerning rheumatology. Reumatismo is published quarterly and is sent free of charge to the Members of the SIR who regularly pay the annual fee. Those who are not Members of the SIR as well as Corporations and Institutions may also subscribe to the Journal.

Topics Covered (Recognized by AI)

Medicine99.8%Biology78.1%Internal medicine75.2%Immunology51.6%Pathology48.1%Surgery34.2%Dermatology33.7%Genetics30.7%Rheumatoid arthritis29%Chemistry26.8%Disease25.2%Arthritis22.7%Endocrinology22.6%Biochemistry22.4%Psychology21.2%

Primary Research Areas

Rheumatology

Official Website NLM PubMed Catalog SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRESCI2026

RHEUMATOLOGY

Rank48/58

IndexESCI

JCIESCI2026

RHEUMATOLOGY

Rank53/58

IndexESCI

Category	Index	Rank	Quartile
RHEUMATOLOGY	JCRESCI	48/58	Q4
RHEUMATOLOGY	JCIESCI	53/58	Q4

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF1.2

Articles / Year53

Total Citations1

2025

IF1

Articles / Year297

Total Citations25

2024

IF1.2

Articles / Year50

Total Citations127

2023

IF1.4

Articles / Year44

Total Citations127

2022

IF—

Articles / Year28

Total Citations130

Year	Impact Factor	Articles / Year	Total Citations
2026	1.2	53	1
2025	1	297	25
2024	1.2	50	127
2023	1.4	44	127
2022	—	28	130
2021	—	32	329
2020	—	37	301
2019	—	36	337
2018	—	38	494
2017	—	33	352
2016	—	44	788
2015	—	22	207

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #17,845Scopus Q4Diamond OASCImago Profile

Scopus Coverage:1952-1977, 1985-2025

•

Scopus Broad Areas:Medicine

Scopus Citation Rank (SJR)Q4

0.283

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q4

Citations / Doc (2 years)

1.00

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

100% Free

Diamond Open Access: Authors publish completely free of charge with zero author-facing fees.

Diamond Open Access

Scopus 3-Year Publication & Citation Window

3-Year Citations110

3-Year Documents106

Citable Documents96

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate53.9%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

RheumatologyQ4

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 8.3%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

4区 (Zone 4)Medicine

Minor Category (Specific Field):

4区RHEUMATOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Reumatismo (ISSN: 0048-7449) is a peer-reviewed international scholarly journal in the field of RHEUMATOLOGY, published by PAGEPress Publications in Italy. The periodical holds a Journal Impact Factor (JIF) of 1.20, ranking in quartile Q4 of Web of Science (ESCI), a Scopus SJR indicator of 0.283 (Q4), an H-index of 34.

The journal enforces rigorous peer evaluation with an annual output of approximately 28 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with Diamond Open Access (100% free of author APC charges). It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.